Skip to main content

Table 2 Days of sick leave due to respiratory and gastrointestinal diseases within the 90 days of observation

From: Effects of the regular intake of the probiotic Lactobacillus reuteri (DSM 17938) on respiratory and gastrointestinal infections in a workplace setting: a double-blind randomized placebo-controlled trial

  Intervention group Control group
  (n = 79) (n = 80)
Total number of days under observation 7,110 7,200
Total number of days of sick leave due to respiratory and gastrointestinal diseases 176.9 161.5
Number of days of sick leave as a percentage of the days under observation 2.49% 2.24%
Number of days of sick leave per participant   
  Mean 2.24 2.02
  Standard deviation 4.74 4.28
  Minimum 0 0
  Maximum 30 24
Number of participants with at least one day of sick leave during the intervention period 28 (35.4%) 24 (30.0%)
Number of days of sick leave for participants with at least one day of sick leave   
  Median 5.0 5.0
  Mean 6.32 6.73
  Standard deviation 6.19 5.45
  Minimum 1 1
  Maximum 30 24